The 2019 balance sheet of Side Effect Pharmaceutical shows average shareholders' equity of $9,996 million, net operating profit after-tax of $2,308 million, net income of $2,513 million, and common shares issued of 950,044 million.Side Effect has not issued any preferred shares.Side Effect's return on equity (ROE) for 2019 is:

Question 1 options:

A)

30.7%

B)

25.1%

C)

37.6%

D)

1. 36.4%

Bloodbath and Beyond reports the following:

20192018Net sales$5,456,650$5,702,613Operating income519,233540,922Net income318,022369,416Asset turnover0.840.92

Compute Bloodbath and Beyond's return of assets (ROA).

Question 2 options:

4.9%

8.2%

2.7%

1. 3.1%

The 2019 financial statements ofBroken Pipeline, Inc.reveal average shareholders' equity of $837,283 thousand, net operating profit after tax of $48,032 thousand, net income of $29,068 thousand, and average net operating assets of $354,414 thousand.

Broken Pipeline's return on equity (ROE) for the year is . . .

Question 3 options:

A)

13.8%

B)

14.3%

C)

3.5%

D)

6.9%